Profile data is unavailable for this security.
About the company
Fresenius Medical Care AG & Co. KGaA is a Germany-based kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
- Revenue in EUR (TTM)18.39bn
- Net income in EUR806.29m
- Incorporated2006
- Employees123.15k
- LocationFresenius Medical Care AG & Co KGaAElse-Kroener-Strasse 1BAD HOMBURG VOR DER HOHE 61352GermanyDEU
- Phone+49 61726090
- Fax+49 61 726092301
- Websitehttps://www.freseniusmedicalcare.com/
| Holder | Shares | % Held |
|---|---|---|
| Harris Associates LPas of 10 Mar 2022 | 14.27m | 4.86% |
| Dodge & Coxas of 15 Feb 2022 | 8.83m | 3.01% |
| Pzena Investment Management LLCas of 20 Apr 2022 | 8.82m | 3.01% |
| Artisan Partners LPas of 12 Jul 2022 | 8.79m | 2.99% |
| Templeton Global Advisors Ltd.as of 30 Jun 2022 | 6.06m | 2.07% |
| The Vanguard Group, Inc.as of 05 Aug 2022 | 5.49m | 1.87% |
| Norges Bank Investment Managementas of 31 Dec 2021 | 3.99m | 1.36% |
| FIL Investment Advisors (UK) Ltd.as of 31 May 2022 | 3.53m | 1.20% |
| BlackRock Fund Advisorsas of 03 Aug 2022 | 3.51m | 1.20% |
| DWS Investment GmbHas of 04 Aug 2022 | 2.41m | 0.82% |
